Impaired mitochondrial maturation of sulfite oxidase in a patient with severe sulfite oxidase deficiency.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
01 09 2019
Historique:
received: 09 04 2019
revised: 09 04 2019
accepted: 07 05 2019
pubmed: 28 5 2019
medline: 10 3 2020
entrez: 26 5 2019
Statut: ppublish

Résumé

Sulfite oxidase (SO) is encoded by the nuclear SUOX gene and catalyzes the final step in cysteine catabolism thereby oxidizing sulfite to sulfate. Oxidation of sulfite is dependent on two cofactors within SO, a heme and the molybdenum cofactor (Moco), the latter forming the catalytic site of sulfite oxidation. SO localizes to the intermembrane space of mitochondria where both-pre-SO processing and cofactor insertion-are essential steps during SO maturation. Isolated SO deficiency (iSOD) is a rare inborn error of metabolism caused by mutations in the SUOX gene that lead to non-functional SO. ISOD is characterized by rapidly progressive neurodegeneration and death in early infancy. We diagnosed an iSOD patient with homozygous mutation of SUOX at c.1084G>A replacing Gly362 to serine. To understand the mechanism of disease, we expressed patient-derived G362S SO in Escherichia coli and surprisingly found full catalytic activity, while in patient fibroblasts no SO activity was detected, suggesting differences between bacterial and human expression. Moco reconstitution of apo-G362S SO was found to be approximately 90-fold reduced in comparison to apo-WT SO in vitro. In line, levels of SO-bound Moco in cells overexpressing G362S SO were significantly reduced compared to cells expressing WT SO providing evidence for compromised maturation of G362S SO in cellulo. Addition of molybdate to culture medium partially rescued impaired Moco binding of G362S SO and restored SO activity in patient fibroblasts. Thus, this study demonstrates the importance of the orchestrated maturation of SO and provides a first case of Moco-responsive iSOD.

Identifiants

pubmed: 31127934
pii: 5498729
doi: 10.1093/hmg/ddz109
doi:

Substances chimiques

Biomarkers 0
Recombinant Proteins 0
Sulfite Oxidase EC 1.8.3.1

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2885-2899

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Daniel Bender (D)

Department of Chemistry, Institute for Biochemistry, University of Cologne, 50674 Cologne, Germany.
Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne Germany.

Alexander Tobias Kaczmarek (AT)

Department of Chemistry, Institute for Biochemistry, University of Cologne, 50674 Cologne, Germany.
Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne Germany.

Jose Angel Santamaria-Araujo (JA)

Department of Chemistry, Institute for Biochemistry, University of Cologne, 50674 Cologne, Germany.

Burkard Stueve (B)

Abteilung für Kinderneurologie, Epileptologie und Sozialpädiatrie, Kliniken Köln, Kinderkrankenhaus, 51058 Cologne, Germany.

Stephan Waltz (S)

Abteilung für Kinderneurologie, Epileptologie und Sozialpädiatrie, Kliniken Köln, Kinderkrankenhaus, 51058 Cologne, Germany.

Deniz Bartsch (D)

Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne Germany.

Leo Kurian (L)

Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne Germany.

Sebahattin Cirak (S)

Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne Germany.
Klinik für Kinderheilkunde und Jugendmedizin, Uniklinikum Köln, 50937 Cologne, Germany.

Guenter Schwarz (G)

Department of Chemistry, Institute for Biochemistry, University of Cologne, 50674 Cologne, Germany.
Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH